Conference Coverage

Nearly one in three patients with IBD affected by skin lesions


 

FROM ECCO 2023

Skin lesions add to patient misery

“Skin lesions are considered a burden to patients with IBD and add to their suffering,” said Sara Mesilhy, MBBS, a gastroenterologist with the Royal College of Physicians in the United Kingdom, who was not affiliated with the research.

The severity and location of the disease appears to play a role because researchers found extensive ulcerative colitis may carry a higher risk for the development of skin lesions, Dr. Mesilhy noted.

The first step when facing skin lesions is to control the disease activity via the best treatment option, Dr. Mesilhy suggested.

The study was independently supported. Dr. Jonaitis and Dr. Mesilhy have disclosed no relevant financial relationships.

A version of this article originally appeared on Medscape.com.

Pages

Recommended Reading

Dupilumab treats itch and clears lesions in prurigo nodularis patients
Federal Practitioner
FDA acts against sales of unapproved mole and skin tag products on Amazon, other sites
Federal Practitioner
Why it’s important for dermatologists to learn about JAK inhibitors
Federal Practitioner
Pandemic caused treatment delay for half of patients with CTCL, study finds
Federal Practitioner
Have you heard of VEXAS syndrome?
Federal Practitioner
Small study finds high dose vitamin D relieved toxic erythema of chemotherapy
Federal Practitioner
Could ChatGPT write this column?
Federal Practitioner
FDA accepts application for topical molluscum treatment
Federal Practitioner
FDA to review dupilumab for treating chronic spontaneous urticaria
Federal Practitioner
Silicone-based film for radiation dermatitis: It works, so why isn’t it used?
Federal Practitioner